NeuroOne Medical Technologies Reports Preliminary FY25 Results Of $9.1M Product Revenue And $6.6M Cash On Hand
Benzinga Newsdesk 1 year ago
EarningsNewsGuidance
Preliminary Results On October 6, 2024, the Company reported the following preliminary unaudited fiscal year 2025 financial and operational results: ●Achieved annual total product revenue of
Preliminary Results
On October 6, 2024, the Company reported the following preliminary unaudited fiscal year 2025 financial and operational results:
| ● | Achieved annual total product revenue of approximately $9.1 million. |
| ● | Cash and cash equivalents of approximately $6.6 million at September 30, 2025. |